These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5565254)

  • 1. EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis.
    Keskiner A; Itil T; Han H; Hsu W; Ulett G
    Psychopharmacologia; 1971; 20(3):230-41. PubMed ID: 5565254
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J; Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate.
    Kurland AA; Richardson JH
    Psychopharmacologia; 1966; 9(4):320-7. PubMed ID: 4871473
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe depressive mood changes following slow-release intramuscular fluphenazine injection.
    De Alarcon R; Carney MW
    Br Med J; 1969 Sep; 3(5670):564-7. PubMed ID: 5808010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluphenazine hydrochloride on digital computer sleep prints of schizophrenic patients.
    Itil TM; Hsu W; Saletu B; Klingenberg H
    Dis Nerv Syst; 1971 Nov; 32(11):751-8. PubMed ID: 4331969
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)].
    Chen PC
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):871-83. PubMed ID: 570538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term use of high doses of fluphenazine enanthate and fluphenazine decanoate.
    Verhaegen JJ
    Compr Psychiatry; 1975; 16(4):357-62. PubMed ID: 1157479
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
    van Praag HM; Dols LC
    Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluphenazine enanthate in sesame oil, a depot preparation.
    Rasmussen OS
    Acta Psychiatr Scand; 1970; 46(3):311-8. PubMed ID: 5490593
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and quantitative EEG changes at different dosage levels of fluphenazine treatment.
    Itil TM; Saletu B; Hsu W; Kiremitci N; Keskiner A
    Acta Psychiatr Scand; 1971; 47(4):440-51. PubMed ID: 4947806
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
    Soni SD; Wiles D; Schiff AA; Bamrah JS
    Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
    Denham J; Adamson L
    Acta Psychiatr Scand; 1971; 47(4):420-30. PubMed ID: 4336483
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of oxyprothepin enanthate and fluphenazine enanthate on the EEG and behaviour in rabbits.
    Likovský Z; Votava Z; Dlabac A
    Act Nerv Super (Praha); 1972; 14(2):127-8. PubMed ID: 5040160
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats.
    Yamamoto T; Ueki S
    J Pharmacobiodyn; 1989 Nov; 12(11):681-92. PubMed ID: 2632765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
    Dreyfuss J; Shaw JM; Ross JJ
    J Pharm Sci; 1976 Sep; 65(9):1310-5. PubMed ID: 966144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.